| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/28/2015 | CN102304132B 高效高立体选择性半合成三尖杉酯类生物碱的方法 Efficient and highly stereoselective semi-synthetic ester alkaloid Cephalotaxaceae method |
| 01/28/2015 | CN102300462B Hcv ns5a的抑制剂 Hcv ns5a inhibitors |
| 01/28/2015 | CN102292339B 作为MetAP-2抑制剂的新杂环化合物 As a new heterocyclic compound MetAP-2 inhibitor |
| 01/28/2015 | CN102283812B 一种治疗脑部疾病的纳米粒制剂 A method for treating brain disorders nanoparticles formulation |
| 01/28/2015 | CN102210754B 一种构建中医肾虚证艾滋病猴模型的方法及用途 A method of TCM kidney deficiency syndrome AIDS monkey model building and use |
| 01/28/2015 | CN102149721B 用于治疗疼痛的氨基膦衍生物 For the treatment of pain aminophosphonic derivative |
| 01/28/2015 | CN102093364B 作为FAK/Pyk2抑制剂的2,4-二氨基-6,7-二氢-5H-吡咯并[2,3]嘧啶衍生物 As FAK / Pyk2 inhibitor 2,4-diamino-6,7-dihydro -5H- pyrrolo [2,3] pyrimidine derivative |
| 01/28/2015 | CN101970428B 羧酰胺化合物及它们作为钙蛋白酶抑制剂的用途 Carboxamide compounds and their use as calpain inhibitor |
| 01/28/2015 | CN101816662B 由雌二醇和胆固醇组成的稳定形状颗粒的制备方法 Preparation of estradiol and cholesterol composed by a stable shape of the particles |
| 01/28/2015 | CN101547905B 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
| 01/27/2015 | US8940943 Cosmetic preparations |
| 01/27/2015 | US8940940 Process for preparing macrocyclic ketones |
| 01/27/2015 | US8940936 Aryloxy phenoxy acrylic compound having HIF-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient |
| 01/27/2015 | US8940927 Activators of glucokinase |
| 01/27/2015 | US8940911 Squarylated lactones inhibitors for bacterial biofilm formation |
| 01/27/2015 | US8940903 Niacin conjugated fatty acid mixtures and their uses |
| 01/27/2015 | US8940902 Treatment of central nervous system disorders |
| 01/27/2015 | US8940901 Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives |
| 01/27/2015 | US8940900 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 01/27/2015 | US8940898 Piperidinyl alkyne orexin receptor antagonists |
| 01/27/2015 | US8940897 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors |
| 01/27/2015 | US8940896 Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis |
| 01/27/2015 | US8940893 Heteroaromatic compounds as BTK inhibitors |
| 01/27/2015 | US8940892 Triazine derivatives for use in the treatment of malaria |
| 01/27/2015 | US8940891 Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto |
| 01/27/2015 | US8940888 Hydrazido derivatives of hyaluronic acid |
| 01/27/2015 | US8940798 Compounds useful for treating and/or preventing disease-associated bone loss |
| 01/27/2015 | US8940797 Foaming alcohol compositions with selected dimethicone surfactants |
| 01/27/2015 | US8940796 Phenylephrine liquid formulations |
| 01/27/2015 | US8940794 Methods and compositions for treating Raynaud's disease |
| 01/27/2015 | US8940793 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease |
| 01/27/2015 | US8940792 Antimicrobial composition and methods for using same |
| 01/27/2015 | US8940791 Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements |
| 01/27/2015 | US8940790 Stable pharmaceutical formulations comprising lubiprostone |
| 01/27/2015 | US8940789 Neurite elongation agent, memory-improving agent and anti-Alzheimer agent comprising 4′-demethylnobiletin or 4′-demethyltangeretin as active ingredient, and process for production of the compound |
| 01/27/2015 | US8940788 Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients |
| 01/27/2015 | US8940787 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 01/27/2015 | US8940786 Non-aqueous taxane nanodispersion formulations and methods of using the same |
| 01/27/2015 | US8940785 Association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it |
| 01/27/2015 | US8940784 Water-soluble CC-1065 analogs and their conjugates |
| 01/27/2015 | US8940782 Composition for repelling and deterring vermin |
| 01/27/2015 | US8940778 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 01/27/2015 | US8940776 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 01/27/2015 | US8940775 Use of derivatives of pentaphyrine as antimicrobial and disinfectant agents |
| 01/27/2015 | US8940774 Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors |
| 01/27/2015 | US8940773 Prolyl hydroxylase inhibitors and methods of use |
| 01/27/2015 | US8940772 Nicotine lozenge composition |
| 01/27/2015 | US8940771 Organic compounds |
| 01/27/2015 | US8940770 Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof |
| 01/27/2015 | US8940769 Biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 01/27/2015 | US8940768 Antifungal triazole derivatives |
| 01/27/2015 | US8940767 Grease-like gel for repelling rodents |
| 01/27/2015 | US8940766 Methods for preventing and/or treating lysosomal storage disorders |
| 01/27/2015 | US8940765 N-linked quinolineamide M1 receptor positive allosteric modulators |
| 01/27/2015 | US8940764 Compositions and methods of treating retinal disease |
| 01/27/2015 | US8940763 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder |
| 01/27/2015 | US8940762 Methods for treating pain |
| 01/27/2015 | US8940761 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors |
| 01/27/2015 | US8940760 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 01/27/2015 | US8940759 Crystalline forms of kinase inhibitors |
| 01/27/2015 | US8940758 Fused heterocyclic compounds |
| 01/27/2015 | US8940756 Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| 01/27/2015 | US8940755 Therapeutic combinations and methods including IRM compounds |
| 01/27/2015 | US8940754 10′-fluorinated Vinca alkaloids provide enhanced biological activity against MDR cancer cells |
| 01/27/2015 | US8940751 Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications |
| 01/27/2015 | US8940750 Inhibitors of bruton's tyrosine kinase |
| 01/27/2015 | US8940748 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
| 01/27/2015 | US8940746 Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine |
| 01/27/2015 | US8940745 Modulators of fatty acid amide hydrolase |
| 01/27/2015 | US8940744 Pyrazolopyrimidine compounds as kinase inhibitors |
| 01/27/2015 | US8940743 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 01/27/2015 | US8940742 Heterocyclic compounds and uses thereof |
| 01/27/2015 | US8940741 Inhibitors of bruton's tyrosine kinase |
| 01/27/2015 | US8940740 Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification |
| 01/27/2015 | US8940739 Compound of a reverse-turn mimetic and a production method and use therefor |
| 01/27/2015 | US8940738 Pyrimidone compounds |
| 01/27/2015 | US8940737 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/27/2015 | US8940736 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 01/27/2015 | US8940735 Metalloenzyme inhibitor compounds |
| 01/27/2015 | US8940734 Fused aminodihydrothiazine derivatives |
| 01/27/2015 | US8940732 Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway |
| 01/27/2015 | US8940731 Substituted pyridyl amide compounds as modulators of the histamine H3 receptor |
| 01/27/2015 | US8940730 Methods and compositions of treating a Flaviviridae family viral infection |
| 01/27/2015 | US8940729 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| 01/27/2015 | US8940728 Substituted noribogaine |
| 01/27/2015 | US8940727 Benzazepine compound |
| 01/27/2015 | US8940726 PRMT5 inhibitors and uses thereof |
| 01/27/2015 | US8940725 Purinone derivative |
| 01/27/2015 | US8940723 Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
| 01/27/2015 | US8940722 Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 01/27/2015 | US8940721 Compositions and methods of treating retinal disease |
| 01/27/2015 | US8940720 Macrocycles as factor XIa inhibitors |
| 01/27/2015 | US8940719 Lithocholic acid analogues that inhibit sialyltransferase |
| 01/27/2015 | US8940718 Antiviral compounds |
| 01/27/2015 | US8940716 Bicyclic heteroaryl compounds as GPR119 modulators |
| 01/27/2015 | US8940715 Lipid-regulating agent and use thereof |
| 01/27/2015 | US8940714 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
| 01/27/2015 | US8940713 Micro-RNA family that modulates fibrosis and uses thereof |
| 01/27/2015 | US8940712 Micro-RNA family that modulates fibrosis and uses thereof |
| 01/27/2015 | US8940711 Micro-RNA family that modulates fibrosis and uses thereof |